Device developer Merxin has announced the availability of its MRX001 “off the shelf” multidose dry powder inhaler.
According to an announcement on the website of Merxin sister company Aedestra, the blister-based DPI is designed for developers of generic combination products planning to submit a 505(j) application.
Read the Aedestra announcement.
published on
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
